These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3309998)
21. [Immunohistochemical study of cancer tissues. 1. Special reference to Leu-11b positive lymphocytes (NK cells)]. Ogawa Y; Maeda T; Inomata T; Yoshida S; Seguchi H; Kishimoto S; Saito H; Hirota S; Osaki T Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1236-42. PubMed ID: 2976419 [No Abstract] [Full Text] [Related]
22. Interactions between autologous CD4+ and CD8+ T lymphocytes and human squamous cell carcinoma of the head and neck. Okada K; Yasumura S; Muller-Fleckenstein I; Fleckenstein B; Talib S; Koldovsky U; Whiteside TL Cell Immunol; 1997 Apr; 177(1):35-48. PubMed ID: 9140094 [TBL] [Abstract][Full Text] [Related]
23. Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma. Kerrebijn JD; Simons PJ; Balm AJ; Tas M; Knegt PP; de Vries N; Tan IB; Drexhage HA Head Neck; 1996; 18(4):335-42. PubMed ID: 8780944 [TBL] [Abstract][Full Text] [Related]
24. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report. Rabin BS; Johnson J; Claassen D Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437 [TBL] [Abstract][Full Text] [Related]
25. Head and neck squamous cell carcinoma cell line-induced suppression of in vitro lymphocyte proliferative responses. Lapointe H; Lampe H; Banerjee D Otolaryngol Head Neck Surg; 1992 Feb; 106(2):149-58. PubMed ID: 1738546 [TBL] [Abstract][Full Text] [Related]
26. In vivo and in vitro activation of NK cytotoxicity with IL-2. Ibayashi Y; Tokuda Y; Saks ER; Sarna GP; Golub SH Prog Clin Biol Res; 1987; 244():275-85. PubMed ID: 3498954 [No Abstract] [Full Text] [Related]
27. Cellular immune response in squamous cell carcinomas of head and neck: evaluation by histological indices. Ariz M; Ahmad KN; Khan AA; Hasan SA Indian J Pathol Microbiol; 1986 Oct; 29(4):392-9. PubMed ID: 3817970 [No Abstract] [Full Text] [Related]
28. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells. Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523 [TBL] [Abstract][Full Text] [Related]
29. [The alternation of peripheral lymphocyte subsets in head and neck carcinoma]. Mitarai K; Tsukuda M; Mochimatsu I; Kubota A; Sawaki S Gan No Rinsho; 1986 Jul; 32(8):849-54. PubMed ID: 3747146 [TBL] [Abstract][Full Text] [Related]
30. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials. Browder JP; Chretien PB Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354 [No Abstract] [Full Text] [Related]
31. Tissue-cultured head and neck tumors: their use in in vitro assays of immune response. Aust JC; Rabuzzi D; Reed G Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1977; 84(3 Pt 2):ORL602-8. PubMed ID: 196378 [TBL] [Abstract][Full Text] [Related]
32. Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck. Mayer A; Andratschke M; Pauli C; Graefe H; Kristina K; Wollenberg B Anticancer Res; 2005; 25(6B):4075-80. PubMed ID: 16309201 [TBL] [Abstract][Full Text] [Related]
33. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo. Whiteside TL; Sung MW; Nagashima S; Chikamatsu K; Okada K; Vujanovic NL Clin Cancer Res; 1998 May; 4(5):1135-45. PubMed ID: 9607570 [TBL] [Abstract][Full Text] [Related]
34. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients. Mickel RA; Kessler DJ; Taylor JM; Lichtenstein A Cancer Res; 1988 Sep; 48(17):5017-22. PubMed ID: 3409231 [TBL] [Abstract][Full Text] [Related]
35. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture. Rangel R; Rocha L; Ramirez JL; Ibarra MJ; Solorza G; Monroy A; Ramirez MA; Herrera A; Weiss-Steider B Eur Cytokine Netw; 1995; 6(3):195-202. PubMed ID: 8589277 [TBL] [Abstract][Full Text] [Related]
36. Allogeneic cell-mediated testing for human tumor antigens. Takasugi M; Ward PH; Mickey MR; Terasaki PI Natl Cancer Inst Monogr; 1972 Dec; 35():251-7. PubMed ID: 4659048 [No Abstract] [Full Text] [Related]
37. Modulation of immunity in cancer patients by prostaglandin antagonists. Braun DP; Taylor SG; Harris JE Prog Clin Biol Res; 1989; 288():439-48. PubMed ID: 2785695 [No Abstract] [Full Text] [Related]
38. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824 [TBL] [Abstract][Full Text] [Related]
39. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Hartmann E; Wollenberg B; Rothenfusser S; Wagner M; Wellisch D; Mack B; Giese T; Gires O; Endres S; Hartmann G Cancer Res; 2003 Oct; 63(19):6478-87. PubMed ID: 14559840 [TBL] [Abstract][Full Text] [Related]
40. [Modulation with phorbol myristate acetate and staurosporine of interleukin 2- induced proliferation and nonspecific cytotoxicity of rat lymphocytes]. Anisimov AG; Bolotnikov IA Biull Eksp Biol Med; 1996 Oct; 122(10):394-8. PubMed ID: 9081434 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]